首页> 外文期刊>Hematology >Alpha thalassemia gene mutations in neonates from Mazandaran, Iran, 2012
【24h】

Alpha thalassemia gene mutations in neonates from Mazandaran, Iran, 2012

机译:伊朗Mazandaran,2012年新生儿的Alpha地中海贫血基因突变

获取原文
           

摘要

Aim Alpha thalassemia is one of the most prevalent disorders worldwide and carrier frequency of the disease is varied in different parts of the world. Although different studies in Iran and Mazandaran province have been carried out to identify different mutations of alpha globin gene among people with low hematological indices, frequencies of these mutations were unknown in general population, and thus the aim of this study was to evaluate the carrier frequencies of alpha globin gene mutations among neonates in Mazandaran. Material and methods Four hundred and twelve neonates were collected from a delivery ward of a hospital in Sari. DNA was extracted from their cord blood samples using phenol-chloroform-based method. For the detection of five common alpha thalassemia gene mutations, multiplex-GAP-PCR and PCR-RFLP methods were applied. Results Sixty three (15.29%, confidence interval, CI 95%: 11.81–18.77) of investigated neonates had at least one of the five evaluated mutations. The -αsup3.7/sup deletion had the highest frequency (9.7%, CI 95%: 6.84–12.56) and none of the neonates had –supMed/sup double gene deletion. The -αsup4.2/sup deletion, αααsupanti3.7/sup triplication, and αsup?5nt/sup mutations had frequencies of 4.1% (CI 95%: 2.19–36.01), 2.2% (CI 95%: 0.78–3.62), and 0.49% (CI 95%: ?0.18–1.16), respectively. Discussion Our study showed that in most of the alpha thalassemia carriers just one copy of alpha globin gene was absent and they are not at risk of having children with Hb H disease or hydrops fetalis; however, up to 2.2% of neonates were carriers for αααsupanti3.7/sup triplication and they will be at risk for having a child with thalassemia intermediate if they marry a person which is a carrier of beta thalassemia.
机译:目的Alpha地中海贫血是世界上最流行的疾病之一,该疾病的携带者频率在世界不同地区有所不同。尽管在伊朗和Mazandaran省进行了不同的研究来确定低血液学指标人群中α珠蛋白基因的不同突变,但是这些突变的频率在一般人群中尚不清楚,因此,本研究的目的是评估携带者的频率赞丹兰新生儿中α珠蛋白基因突变的检测材料和方法从萨里一家医院的分娩病房收集了412名新生儿。使用基于苯酚-氯仿的方法从其脐血样本中提取DNA。为了检测五个常见的α地中海贫血基因突变,应用了多重GAP-PCR和PCR-RFLP方法。结果接受调查的新生儿中有63名(15.29%,置信区间,CI 95%:11.81-18.77)具有至少五个评估突变之一。 -α 3.7 缺失的发生率最高(9.7%,CI 95%:6.84–12.56),而新生儿均没有– Med 双基因缺失。 -α 4.2 缺失,ααα anti3.7 三重和α?5nt 突变的频率为4.1%(CI 95%:2.19– 36.01),2.2%(CI 95%:0.78–3.62)和0.49%(CI 95%:0.18–1.16)。讨论我们的研究表明,在大多数α地中海贫血携带者中,只有一个拷贝的α珠蛋白基因缺失,而且他们没有患Hb H病或胎儿积水的风险。然而,高达2.2%的新生儿是携带ααα anti3.7 的携带者,如果他们与β地中海贫血的携带者结婚,则有患地中海贫血的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号